Safety of Long-term Treatment With Certolizumab Pegol in Patients With Crohn's Disease, Based on a Pooled Analysis of Data From Clinical Trials
Author:
Publisher
Elsevier BV
Subject
Gastroenterology,Hepatology
Reference42 articles.
1. Infection and musculoskeletal conditions: bacterial and opportunistic infections during anti-TNF therapy;Strangfeld;Best Pract Res Clin Rheumatol,2006
2. Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor;Winthrop;Nat Clin Pract Rheumatol,2006
3. Rates of serious infections, opportunistic infections, inflammatory bowel disease, and malignancies in subjects receiving etanercept vs. controls from clinical trials in ankylosing spondylitis: a pooled analysis;van der Heijde;Scand J Rheumatol,2014
4. Inflammatory bowel disease is associated with an increased risk of melanoma: a systematic review and meta-analysis;Singh;Clin Gastroenterol Hepatol,2014
5. Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease;Long;Gastroenterology,2012
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Psoriatic Alopecia and Paradoxical Psoriasis Induced by Adalimumab Successfully Treated with Certolizumab: Clinical, Trichoscopic, and in vivo Reflectance Confocal Microscopy Features;Skin Appendage Disorders;2022-12-08
2. Whither digitalis? What we can still learn from cardiotonic steroids about heart failure and hypertension;American Journal of Physiology-Heart and Circulatory Physiology;2022-12-01
3. A case of psoriatic alopecia secondary to certolizumab pegol: clinical and trichoscopic evaluation;International Journal of Dermatology;2022-05-17
4. Is it time to include older adults in inflammatory bowel disease trials? A call for action;The Lancet Healthy Longevity;2022-05
5. Anti-cytokine therapy and small molecule agents for the treatment of inflammatory bowel disease;European Cytokine Network;2021-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3